Australian Clinical Labs Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs. It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Key Metrics
PE ratio
16.75
PB ratio
3.04
Dividend yield
4.50%
Beta
1.01
Market cap
$515.15M
Enterprise value
$809.50M
Company profile
| Industry / Sector | Diagnostics & Research / Healthcare |
|---|---|
| Full time employees | 4700 |
| Website | https://www.clinicallabs.com.au |
| Mailing address | 1868-1892 Dandenong Road Clayton VIC 3168 Australia |
| Phone / Fax | 61 1 3004 53688 / 61 3 9538 6777 |
Dividends
More: Australian Clinical Labs Dividend history, yield and payout ratio
Dividend yield
4.50%
Dividend amount
$0.13
Payout ratio
73.31%
5Y Avg. yield
-%
Australian Clinical Labs paid $0.13 dividend and the ex-dividend date was 01 Sep 2025.The dividend payout ratio is 73.31%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ACL dividend payout ratio is between 70-90%. The lower dividend payout ratio is preferrable since it provides company margin to grow the dividends in future.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Australian Clinical Labs.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Ms. Melinda McGrath | CEO, MD & Executive Director | ||
| Mr. Matthew Cordingley | Chief Financial Officer | ||
| Mr. Anthony Friedli | Chief Operating Officer | ||
| Mr. Sean Jackson | Chief Information Officer | ||
| Mr. Joe Geran | National Marketing Director | ||
| Associate Prof. Tony Landgren | National Medical Director & Chief Pathologist | ||
| Mr. Chris Brownlow | Chief Executive Officer of New South Wales & Australian Capital Territory | ||
| Ms. Shae Seymour | Chief Risk Officer & CEO of WA/SA/NT | ||
| Ms. Eleanor Padman B.A., FCIS | Company Secretary | ||
| Mr. Rob Izzard | Chief Executive Officer of ACL Commercial Pathology |
Profitability and management effectiveness
Profit margin
4.38%
Operating margin
10.94%
Return on assets
7.28%
Return on equity
18.77%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Australian Clinical Labs is 515.15M and its enterprise value is 809.50M. The enterprise value to revenue ratio of ACL is 1.09. The enterprise value to EBITDA ratio of ACL is 9.95.
The ACL's stocks Beta value is 1.01 making it 1% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Australian Clinical Labs (ACL)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Australian Clinical Labs (ASX:ACL) Frequently Asked Questions
1. What is Australian Clinical Labs's Stock Symbol?
Australian Clinical Labs trades on ASX under the ticker symbol "ACL".
2. What is Australian Clinical Labs's stock price today?
One share of ACL stock can currently be purchased for approximately $2.68.
3. How can I contact Australian Clinical Labs?
Australian Clinical Labs's mailing address is 1868-1892 Dandenong Road Clayton VIC 3168 Australia. The company can be reached via phone at 61 1 3004 53688.
4. What is Australian Clinical Labs's official website?
The official website of Australian Clinical Labs is https://www.clinicallabs.com.au.